2-bromo-2',5'-dihydroxychalcone analogue Inhibits Endothelial Migration by Targeting VEGF-induced ERK 1/2 Phosphorylation
A. Hussain, J. Festa, H. Singh
This paper evaluates a 2-bromo-2',5'-dihydroxychalcone analogue (AH9) for its ability to inhibit endothelial cell migration by blocking VEGF-induced ERK1/2 phosphorylation, showing comparable efficacy to Sorafenib.
bioRxiv · Sep 11, 2023 · PreprintPharmacology & Toxicology